On rising insulin prices, lawmaker tells pharma execs: ‘Your days are numbered’
CNNCNN — Lawmakers tensed with frustration, some clenching their jaws, while grilling a panel of pharmacy and pharmaceutical company executives about the soaring cost of insulin during a congressional hearing on Wednesday. Ahead of Wednesday’s hearing, pharmaceutical company Sanofi announced plans to reduce the price of insulin for qualifying patients to $99 a month for up to 10 boxes of pens or 10-milliliter vials. US Senate Finance Committee Chairman Chuck Grassley of Iowa, who helped launch a bipartisan investigation into insulin prices in February, called the move “a step in the right direction” in a written statement Wednesday. That’s not how a functioning marketplace works.” Health insurer Cigna said last week that it’s launching a program that will cap out-of-pocket expenses at $25 for a 30-day supply of insulin. “In most cases, people who use insulin will see lower out-of-pocket costs without any increased cost to the plan,” the company said.